SINOPHARM GRP CO. H YC 1SINOPHARM GRP CO. H YC 1SINOPHARM GRP CO. H YC 1

SINOPHARM GRP CO. H YC 1

No trades
See on Supercharts

X2S fundamentals

SINOPHARM GRP CO. H YC 1 financial statements, including revenue, expenses, and profit

The total revenue of X2S for the last semiannual is 39.08 B EUR, and it's 2.36% higher compared to the previous semiannual. The net income of H2 24 is 451.16 M EUR.

Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: EUR
TTM
Total revenueYoY growth
Gross profitYoY growth
Pretax incomeYoY growth
Net incomeYoY growth
EBITDAYoY growth
EBITYoY growth